Search results for “Target antigen” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 2,885 patents, we discovered top 459 key players by total patent application. F. Hoffmann-La Roche Ltd., Immunomedics, Inc., Chugai Pharmaceutical Co., Ltd. are dominant in this area. They take 8.32% of the total patent filing.
Switzerland
Patent: 107
New Jersey, United States
Patent: 68
Tokyo-to, Japan
Patent: 65
New York, United States
Patent: 61
Massachusetts, United States
Patent: 60
California, United States
Patent: 53
California, United States
Patent: 48
STARTUP
United Kingdom
Patent: 34
Basel-Stadt, Switzerland
Patent: 33
California, United States
Patent: 33
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 160 patents, we discovered top 22 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Autolus Ltd., Noile-Immune Biotech, Inc. are active in this area.
STARTUP
France
Patent: 52
STARTUP
United Kingdom
Patent: 34
STARTUP
Tokyo-to, Japan
Patent: 18
STARTUP
Shanghai Shi, China
Patent: 17
STARTUP
Gyeonggi-do, South Korea
Patent: 8
STARTUP
Massachusetts, United States
Patent: 4
STARTUP
IntelliStem Technologies, Inc.
Ontario, Canada
Patent: 3
STARTUP
Auctus Biologics, Inc.
Louisiana, United States
Patent: 3
STARTUP
California, United States
Patent: 3
STARTUP
Jiangsu Sheng, China
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1,461 patents applied in the last 5 years. We discover 399 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Eureka Therapeutics, Inc. take 9.24% of patent filing during this period.
Switzerland
Patent: 49
New York, United States
Patent: 47
California, United States
Patent: 39
STARTUP
United Kingdom
Patent: 33
California, United States
Patent: 33
STARTUP
France
Patent: 24
Baden-Württemberg, Germany
Patent: 22
Zhejiang Sheng, China
Patent: 21
France
Patent: 21
BEIJING DCTY® BIOTECH CO.,LTD
Beijing Shi, China
Patent: 20
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1,461 patents in last 5 years, we discover 281 new entrants. Sorrento Therapeutics, Inc., Affimed GmbH, Institut Curie are the most active new entrants in this area.
California, United States
Patent: 33
Baden-Württemberg, Germany
Patent: 22
France
Patent: 21
Zhejiang Sheng, China
Patent: 21
BEIJING DCTY® BIOTECH CO.,LTD
Beijing Shi, China
Patent: 20
STARTUP
Tokyo-to, Japan
Patent: 18
STARTUP
Shanghai Shi, China
Patent: 17
South Korea
Patent: 17
United States
Patent: 14
Yamaguchi-ken, Japan
Patent: 14
Research Institutions
Order by:
Innovation Intensity
With the analysis among 1,204 patents, we discovered top 151 universities and scientific research institutions by total patent application. The University of Queensland, The Johns Hopkins University, Zhejiang University are dominant in this area. They take 11.46% of the total patent filing.
Queensland, Australia
Patent: 27
United States
Patent: 23
Zhejiang Sheng, China
Patent: 21
Texas, United States
Patent: 20
Massachusetts, United States
Patent: 18
Massachusetts, United States
Patent: 18
South Korea
Patent: 17
Vaud, Switzerland
Patent: 16
United Kingdom
Patent: 15
Nebraska, United States
Patent: 15
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: